At Takeda, we are transforming the pharmaceutical industry through our R&D-driven market leadership and being a values-led company. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). At Takeda R&D, we do more for patients by translating science into highly innovative, life-changing medicines across our core Therapeutic Areas in Innovative Biopharma: Oncology, Rare Genetics and Hematology, Neuroscience and Gastroenterology. Join us as a Project Manager, in US Medical Therapeutic Area Project Management in Lexington, MA. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). Takeda is also dedicated to supporting your practice, so inside you will find:. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. To maximize the impact of our innovative medicines our R&D efforts are focused on four therapeutic areas: Oncology, Gastroenterology, Neuroscience and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. Our Stories . We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. Do you wish to proceed? We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. Takeda fosters a collaborative and stimulating work environment filled with opportunity and the chance to make a difference in people's lives. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). Thomas Wozniewski, Takeda Global Manufacturing & Supply Officer, commented: “This investment shows our commitment to Ireland and the importance as a production location for Takeda. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). Access to patient educational information you can easily print and share Support for you. At Takeda, we are transforming the pharmaceutical industry through our R&D-driven market leadership and being a values-led company. You are now leaving Takeda for Healthcare Professionals. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people's lives by advancing the frontier of new treatment options and … Our Stories A selection of ... Takeda has a 75+ year pioneering legacy in producing plasma-derived therapies, and is established as a top three global player with end-to-end capabilities spanning the plasma value chain from donor to patient. Join us as Rare Diseases Therapeutic Area Unit (TAU ) Head of Global Program Management in in our Cambridge, MA office. By proceeding, you will be entering the non-promotional Takeda Medical Information Site. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Rare Diseases and Neuroscience. Information on financial assistance programs for Takeda’s products . Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and … The Project Manager, US Medical Therapeutic Area (TA) Project Management will provide project management support across multiple therapeutic areas to the PMO management team. We have a singular focus on diseases affecting patient groups with the most urgent needs and for whom treatments do not exist or are not good enough. By proceeding, you will be entering the educational section of the website. “Soticlestat has emerged as an important late-stage molecule in our portfolio, which focuses predominantly on rare neurological and neuromuscular diseases with great unmet need,” Sarah Sheikh, head, Neuroscience Therapeutic Area Unit at Takeda said in a statement. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment … Oncology is one of four Takeda’s core therapeutic areas, and with the new production line w e will make our supply chain for both products more robust and flexible, to be prepared also for future growth.” Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI). Drive engagement with advocacy groups aligned with Takeda's therapeutic focus; identify, create, and sustain innovative partnerships to support brand goals. Takeda is committed to the health of your patients, so inside you will find:. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). As a Director, Therapeutic Area Policy and Advocacy working on the Public Affairs team, you will be empowered to direct and collaborate across functional areas to develop and execute government affairs strategies that support the commercial business units. Takeda has made plasma therapies one of its core therapeutic areas, and it's advancing potential COVID-19 therapies in an alliance with several other drugmakers in the field. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetic and Hematology, Neuroscience, and Gastroenterology (GI).